Home > Financial Ratios > SENORES PHARMACEUTICALS

SENORES PHARMACEUTICALS
Core EBITDA Growth

    Back to All Ratios
SENORES PHARMACEUTICALS is part of below Screeners ↓
Best Quarterly Growth Small Cap Stocks
COMMUNITY POLL
for SENORES PHARMACEUTICALS
Please provide your vote to see the results

SENORES PHARMACEUTICALS Last 5 Year Core EBITDA Growth History

[Consolidated]

Mar2025Mar2024Mar2023Mar2022
   Core EBITDA Growth(%) 145.46171.43577.75-

What is the latest Core EBITDA Growth ratio of SENORES PHARMACEUTICALS ?

The latest Core EBITDA Growth ratio of SENORES PHARMACEUTICALS is 145.46 based on Mar2025 Consolidated results.
Year Core EBITDA Growth
Mar2025145.46
Mar2024171.43
Mar2023577.75
Mar2022-

How is Core EBITDA Growth of SENORES PHARMACEUTICALS Trending?

Years Core EBITDA Growth % Change
Mar2025 145.46
-15.15
Mar2024 171.43
-70.33
Mar2023 577.75
0
Mar2022 0 -

Other Financial Ratios of SENORES PHARMACEUTICALS


Compare Core EBITDA Growth ratio of peers of SENORES PHARMACEUTICALS

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
SENORES PHARMACEUTICALS ₹6,085.7 Cr -5.4% -0.7% 115.2% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹477,408.0 Cr 1.8% 6.8% 17.8% Stock Analytics
DIVIS LABORATORIES ₹206,906.0 Cr 6.7% 18.5% 12.2% Stock Analytics
TORRENT PHARMACEUTICALS ₹185,521.0 Cr -3.7% 5.5% 39.8% Stock Analytics
CIPLA ₹119,032.0 Cr 5.7% 0.6% -1.4% Stock Analytics
DR REDDYS LABORATORIES ₹95,420.1 Cr -2% -15.8% -8.4% Stock Analytics


SENORES PHARMACEUTICALS Share Price vs Sensex


Share Price Returns(%) 1 Week 1 Month 1 Year
SENORES PHARMACEUTICALS

-5.4%

-0.7%

115.2%

SENSEX

1.2%

1.2%

-5.5%


You may also like the below Video Courses